Skip to main content

Table 2 Association of PTR with patient overall survival in locally advanced PDA patients

From: Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma

  OS DSS
Number HR (95%CI) P value Number HR (95% CI) P value
Non-adjusted 4322 0.61 (0.55, 0.68) < 0.001 4055 0.60 (0.54, 0.66) < 0.001
Multivariable adjusted model* 4322 0.59 (0.53, 0.66) < 0.001 4055 0.57 (0.51, 0.65) < 0.001
Matched on propensity score 960 0.59 (0.50, 0.69) < 0.001 960 0.57 (0.47, 0.67) < 0.001
Regression adjusted with propensity score
 Propensity score, continuous 4322 0.61 (0.55, 0.67) < 0.001 4055 0.61 (0.54, 0.68) < 0.001
 Propensity score, quintile 4322 0.62 (0.56, 0.69) < 0.001 4055 0.60 (0.53, 0.67) < 0.001
  1. PTR was the reference (HR: 1). Data are shown as HR (95% CI) P value. *Adjusted model was adjusted for: age, race, sex, year of diagnosis, tumor differentiation, tumor size, tumor location and chemotherapy